Our technology gives researchers the power to map intact tissues with greater clarity and in dimensions never before possible.
“The initial thought of the Spatial Transcriptomics technique was born out of a frustration that many types of analyses we do require taking a cell out of its context. One day, I was pondering whether it would be possible to tag cells in their natural environment, to enable analysis of cells and their niches, rather than taking them out of their context. I continued to think about this during the day, and when walking home from work, I called Joakim Lundeberg to hear his thoughts about the strategy. I vividly remember which street corner I was at and Joakim’s palpable excitement.
The more we spoke about it, the more enthusiastic we got. We found a postdoctoral fellow and two PhD students perfectly suited for the project, and after a short time recruited Patrik Ståhl to direct the development. This is when Spatial Transcriptomics was born.”
JONAS FRISÉN – Co-Founder
is the Tobias Foundation Professor of Stem Cell Research at the Department of Cell and Molecular Biology, Karolinska Institutet, since 2001. Jonas Frisén is internationally recognized for his studies of stem cells in adult organs. He has received several prestigious awards, was an advisor to the Swedish Government on research and is a member of the Nobel assembly at the Karolinska Institute. He was a founder of NeuroNova AB, a biotech company, which initiated clinical studies with two new pharmaceuticals developed by the company for ALS and Parkinson’s disease, respectively, before being acquired by Newron Pharmaceuticals in 2012.
heads the division of Gene Technology, part of the School of Biotechnology, KTH and has broad competence in technology development with previous experience of innovation. Prof Lundeberg heads the Genomics platform at the Science for Life Laboratory (SciLifeLab) which is among the major sequencing sites in Europe and is host for the national platform in MPS.
is a group leader at SciLifeLab. Patrik is an internationally recognized researcher within the genomics field. He has former experience from successful technology innovation and spin off companies.
founded Swedish VC firm Segulah 1994. Adjunct professor in Finance at Stockholm School of Economics 1977-2002. Broad Background in industry and finance. Former CEO for Richard Hägglöf Foundation, Proventus AB, Gota Bank and Segulah.
Chief Executive Officer
has an extensive track record in R&D in both basic science, applied translational medicine and drug discovery and development as manager at Karolinska Institute, Astra AB and AstraZeneca LLC. From 2000 Anders was CEO and CSO in a company that was a leader in applied stem cell R&D, NeuroNova AB, and later brought two molecules into clinical phase I/II. The company was acquired by a listed company, Newron Pharmaceuticals S.p.A., in which Anders was a management team member between 2013 and 2016.
Chief Operation Officer
has experience of working in different European neuroscience and genomics research groups. He was an early employee of the company and has been extensively involved in product R&D and commercialisation.
Who We Are
Our team of experienced biologists and engineers is excited to be at the forefront of the spatial revolution in gene expression analysis. We are convinced Spatial Transcriptomics will become the new golden standard of gene activity analysis for both research and diagnostics. Currently our products are used by major pharmaceutical companies, leading universities and research institutes.